Anne Arundel Eye Center | |
127 Lubrano Dr, Suite 301, Annapolis, MD 21401-7114 | |
(410) 224-2010 | |
(410) 224-3044 |
Full Name | Anne Arundel Eye Center |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 127 Lubrano Dr, Annapolis, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164790531 | NPI | - | NPPES |
226611300 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anne Arundel Eye Center Po Box 62084, Baltimore, MD 21264-2084 Ph: (443) 481-6524 | Anne Arundel Eye Center 127 Lubrano Dr, Suite 301, Annapolis, MD 21401-7114 Ph: (410) 224-2010 |
News Archive
U.S. Health and Human Services Secretary Kathleen Sebelius "administered polio vaccination drops to children in New Delhi on Friday as India marked one year since its last case of the crippling disease," the Associated Press reports (1/13).
Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, announced today that it has completed the renovation and expansion of its Billerica, MA corporate headquarters.
NanoViricides, Inc. (the "Company"), reports that it has signed a research and development agreement with Dr. Eva Harris's laboratory at the University of California, Berkeley (UC Berkeley).
In a newly released report comparing international usage of prescription drugs, Canada ranks thirteenth among 14 countries for cancer drugs launched within the last five years. The study, conducted for the UK Secretary of State for Health, compared 14 countries for their usage of 14 categories of prescription drugs to determine whether the UK is adequately providing for the health needs of its citizens.
According to findings led by researchers at Yale Cancer Center, treatment with the targeted therapy osimertinib following surgery significantly improves disease-free survival (DFS) in patients with early-stage, non-small cell lung cancer (NSCLC) with EGFR gene mutations.
› Verified 5 days ago
Dr. Ryan Shaun Sullivan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2321 Forest Dr, Annapolis, MD 21401 Phone: 410-266-3369 | |
Jonathan Jacesko, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. David A Byman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. Elizabeth C Mcmunn, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-4378 | |
Dr. Jay Thompson Rorick, MD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 888 Bestgate Road, Suite 102, Annapolis, MD 21401 Phone: 410-571-7325 Fax: 410-571-7301 | |
Wenny Tan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1505 Annapolis Mall, Annapolis, MD 21401 Phone: 410-573-2095 | |
Anchor Eyecare Annapolis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 Fax: 410-349-0079 |